Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
342
archived clinical trials in
Restless Leg Syndrome

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Anaheim, CA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
San Diego, CA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Greenwood, CO
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Greenwood, CO
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Wheat Ridge, CO
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Brandon, FL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Brandon, FL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Pembroke Pines, FL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
St. Petersburg, FL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Atlanta, GA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Austell, GA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Austell, GA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Macon, GA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Macon, GA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Elk Grove Village, IL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Normal, IL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Danville, IN
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Danville, IN
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Lenexa, KA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Topeka, KA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Topeka, KA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Crestview Hills, KY
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Lexington, KY
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Louisville, KY
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Baton Rouge, LA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Lafayette, LA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lafayette, LA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Auburn, ME
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Auburn, ME
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Brighton, MA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Brighton, MA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
St. Louis, MO
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Las Vegas, NV
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Toms River, NJ
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Toms River, NJ
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Charlotte, NC
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Greenville, NC
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Cincinnati, OH
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Cleveland, OH
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Dublin, OH
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Dublin, OH
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Tulsa, OK
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Corvallis, OR
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Corvallis, OR
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Portland, OR
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Duncansville, PA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Duncansville, PA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Lafayette Hill, PA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lafayette Hill, PA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Columbia, SC
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Dallas, TX
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
San Antonio, TX
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Walla Walla, WA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
University of Alabama at Birmingham
mi
from
Brimingham, AL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
University of Alabama at Birmingham
mi
from
Brimingham, AL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Scripps Clinic
mi
from
La Jolla, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Research Center of Southern California
mi
from
Oceanside, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Research Center of Southern California
mi
from
Oceanside, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Stanford Center for Human Sleep Research
mi
from
Redwood City, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Stanford Center for Human Sleep Research
mi
from
Redwood City, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Neurological Research Institute
mi
from
Santa Monica, CA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Neurological Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep-Alertness Disorder Center
mi
from
Aurora, CO
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep-Alertness Disorder Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
PAB Clinical Research
mi
from
Brandon, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
MD Clinical
mi
from
Hallandale Beach, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
MD Clinical
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials